EB-116
9-顺视黄醇乙酸酯
Report date: 2025/07/29 13:52:47
NME
Base Information
Drug NameEB-116
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRetinagenix Holdings LLC
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesEluminex Biosciences (Suzhou) Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A